Skip to main content
SpringerLink
Log in

Utilisation d’un test génomique pour évaluer le risque de rechute de cancer du sein : expérience française mono-institutionnelle

  • Conference paper
Cancer du sein : surdiagnostic, surtraitement

  • 211 Accesses

Résumé

La décision de traitement adjuvant des cancers du sein à leur phase précoce reste complexe, et manque d’outils de précision biologique. Les nouvelles classifications moléculaires ont démontré leur impact pronostic. Le score de rechute (SR) de l’Oncotype Dx repose sur une classification génomique, est utilisé en routine aux états-Unis, et pas encore en France.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Author information

Authors and Affiliations

  1. Département d’oncologie médicale, Hôpital Américain de Paris, 92200, Neuilly-sur-Seine

    A. Toledano, H. Lamallem, T. Bouillet, P. Bouffette, C. Brami & P. Ihout

  2. Centre Radiothérapie Hartmann, 92200, Neuilly-sur-Seine

    A. Toledano & H. Lamallem

  3. Breast Cancer Unit, gynécologie, Hôpital américain de Paris, 92200, Neuillysur-Seine

    C. Tibi, J. M. Emmanuelli, F. Chiche, S. Sananes, F. Rollet & J. N. Guglielmina

Authors
  1. A. Toledano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Lamallem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Bouillet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Bouffette
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Brami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Tibi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. M. Emmanuelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Chiche
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Sananes
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Rollet
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. Ihout
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. N. Guglielmina
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Toledano, A. et al. (2012). Utilisation d’un test génomique pour évaluer le risque de rechute de cancer du sein : expérience française mono-institutionnelle. In: Cancer du sein : surdiagnostic, surtraitement. Springer, Paris. https://doi.org/10.1007/978-2-8178-0249-7_53

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0249-7_53

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0248-0

  • Online ISBN: 978-2-8178-0249-7

Publish with us

Policies and ethics

Search

Navigation